For pharmaceutical companies, social media has always been a trickier game. On one hand, social media has emerged as a preferred medium of expression and communication all over the world. On the other hand, there are very strict regulations about what information can be shared by pharma companies.

However, today most of the customers expect the businesses to be present on social media where there can be a direct communication. But the regulation as well as cautious attitude on part of the companies mean that most of the pharma companies find it difficult to go beyond using social media as another PR channel. 

However, this does not mean that the pharmaceutical companies are not using social media. They are innovating use of social media to move closer to their customers. Pfizer, for example, has more than 30 region as well as subject specific social media accounts across Facebook, YouTube, and Twitter. Similarly, other companies are taking to social media increasingly to disseminate information and bring in more transparency.

We, at VOZIQ, analyzed all the social media buzz around big pharmaceutical companies to see how they fair relative to each other on social media. The companies whose buzz we analyzed are:

GSKMerckNovartisPfizerRoche

See on thoughtreach.com